发明名称 |
Nucleic acid encoding a polypeptide having aminotransferase activity, vectors and host cells comprising the nucleic acid |
摘要 |
A method for efficiently producing an optically active amino compound useful as an intermediate for pharmaceutical preparations, agricultural chemicals, or the like, from a ketone compound is provided. Specifically, a polypeptide having high resistance to a water-soluble organic solvent and novel transaminase activity for generating (S)-1-benzyl-3-pyrrolidinone with high optical purity of 93% or more, a gene encoding the same, and a transformant expressing the gene at a high level are also provided herein. |
申请公布号 |
US9481870(B2) |
申请公布日期 |
2016.11.01 |
申请号 |
US201113876400 |
申请日期 |
2011.09.28 |
申请人 |
KANEKA CORPORATION |
发明人 |
Nagasawa Toru;Yoshida Toyokazu;Ishida Kouichi;Ito Noriyuki;Kawano Shigeru;Yasohara Yoshihiko |
分类号 |
C07H21/00;C12N1/21;C12N1/19;C12P17/00;C12P41/00;C12N1/15;C12N9/10;C12P17/10 |
主分类号 |
C07H21/00 |
代理机构 |
Polsinelli PC |
代理人 |
Polsinelli PC |
主权项 |
1. A DNA consisting of a nucleotide sequence encoding a polypeptide selected from the group consisting of:
(a) a polypeptide consisting of an amino acid sequence that is identical to the amino acid sequence of SEQ ID NO: 1 except for a deletion, a substitution, an insertion and/or an addition of 1 to 20 amino acids in SEQ ID NO: 1, wherein said polypeptide acts on 1-benzyl-3-pyrrolidinone in the presence of an amino group donor to generate (S)-1-benzyl-3-aminopyrrolidine with optical purity of 93% enantiomeric excess or more; and (b) a polypeptide consisting of an amino acid sequence that is identical to the amino acid sequence of SEQ ID NO: 1 except for a deletion, a substitution, an insertion and/or an addition of 1 to 20 amino acids in SEQ ID NO: 1, wherein said polypeptide acts on 1-benzyl-3-pyrrolidinone in the presence of an amino group donor to generate (S)-1-benzyl-3-aminopyrrolidine with optical purity of 93% enantiomeric excess or more; and wherein said polypeptide (i) exhibits activity for (S)-1-phenethylamine, benzylamine, and 2-butylamine as amino group donors and does not substantially exhibit activity for β-alanine and 4-aminobutyric acid, (ii) exhibits activity for pyruvic acid and activity for glyoxalic acid as amino group receptors; and/or (iii) retains 10% or more of residual activity after 2 hours of treatment with a solution having a concentration of 80% v/v of 1-propanol, 2-propanol, or acetone compared to the enzymatic activity prior to the treatment. |
地址 |
Osaka JP |